JP2024530325A5 - - Google Patents
Info
- Publication number
- JP2024530325A5 JP2024530325A5 JP2024513383A JP2024513383A JP2024530325A5 JP 2024530325 A5 JP2024530325 A5 JP 2024530325A5 JP 2024513383 A JP2024513383 A JP 2024513383A JP 2024513383 A JP2024513383 A JP 2024513383A JP 2024530325 A5 JP2024530325 A5 JP 2024530325A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/115621 | 2021-08-31 | ||
| CN2021115621 | 2021-08-31 | ||
| PCT/CN2022/115536 WO2023030258A1 (en) | 2021-08-31 | 2022-08-29 | Anti-4-1bb nanobodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530325A JP2024530325A (ja) | 2024-08-16 |
| JP2024530325A5 true JP2024530325A5 (https=) | 2025-09-08 |
Family
ID=85410851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513383A Pending JP2024530325A (ja) | 2021-08-31 | 2022-08-29 | 抗４－１ｂｂナノボディ |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240383993A1 (https=) |
| EP (1) | EP4396234A4 (https=) |
| JP (1) | JP2024530325A (https=) |
| KR (1) | KR20240049829A (https=) |
| CN (1) | CN118176211A (https=) |
| AU (1) | AU2022336889A1 (https=) |
| CA (1) | CA3230481A1 (https=) |
| IL (1) | IL311144A (https=) |
| MX (1) | MX2024002720A (https=) |
| WO (1) | WO2023030258A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026507127A (ja) * | 2023-02-28 | 2026-02-27 | ラノバ メディシンズ リミテッド | Ｃｅａｃａｍ５依存性４－１ｂｂアゴニスト性二重特異性抗体 |
| WO2025214249A1 (en) * | 2024-04-12 | 2025-10-16 | Suzhou Biomissile Pharmaceuticals Co., Ltd. | Anti-4-bb single domain antibodies, bispecific antibodies and uses thereof |
| WO2026075820A1 (en) * | 2024-10-03 | 2026-04-09 | Modernatx, Inc. | 4-1bb binding molecules, nucleic acids encoding same, and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180096789A (ko) * | 2016-01-11 | 2018-08-29 | 인히브릭스, 인크. | 다가 및 다중특이적 41bb-결합 융합 단백질 |
| CN112210010B (zh) * | 2017-01-06 | 2023-12-05 | 优特力克斯有限公司 | 抗-人4-1bb抗体及其应用 |
| EP3710478A1 (en) * | 2017-11-13 | 2020-09-23 | Crescendo Biologics Limited | Molecules that bind to cd137 and psma |
| TW201938194A (zh) * | 2017-12-05 | 2019-10-01 | 日商中外製藥股份有限公司 | 包含結合cd3及cd137的改變的抗體可變區之抗原結合分子 |
| KR20200113228A (ko) * | 2018-01-22 | 2020-10-06 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 항-4-1bb 항체, 이의 항원-결합 단편 및 이의 의학적 용도 |
| WO2020007817A1 (en) * | 2018-07-04 | 2020-01-09 | F. Hoffmann-La Roche Ag | Novel bispecific agonistic 4-1bb antigen binding molecules |
| CN112646031B (zh) * | 2019-10-10 | 2021-12-07 | 天境生物科技(上海)有限公司 | 抗4-1bb纳米抗体及其用途 |
-
2022
- 2022-08-29 WO PCT/CN2022/115536 patent/WO2023030258A1/en not_active Ceased
- 2022-08-29 IL IL311144A patent/IL311144A/en unknown
- 2022-08-29 EP EP22863394.7A patent/EP4396234A4/en active Pending
- 2022-08-29 MX MX2024002720A patent/MX2024002720A/es unknown
- 2022-08-29 AU AU2022336889A patent/AU2022336889A1/en active Pending
- 2022-08-29 CA CA3230481A patent/CA3230481A1/en active Pending
- 2022-08-29 CN CN202280070221.9A patent/CN118176211A/zh active Pending
- 2022-08-29 KR KR1020247009916A patent/KR20240049829A/ko active Pending
- 2022-08-29 JP JP2024513383A patent/JP2024530325A/ja active Pending
- 2022-08-29 US US18/687,277 patent/US20240383993A1/en active Pending
-
2025
- 2025-05-02 US US19/197,775 patent/US20250320307A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7323513B2 (ja) | 抗４－１ｂｂ抗体とその作製及び使用方法 | |
| JP2024530325A5 (https=) | ||
| TWI489996B (zh) | Ｃｄ１２７結合蛋白質 | |
| JP4294596B2 (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| JP2022512653A5 (https=) | ||
| JP2023526774A5 (https=) | ||
| JP2021534762A5 (https=) | ||
| JP7399852B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| WO2018137576A1 (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| JP2023506184A5 (https=) | ||
| JP2011509245A5 (https=) | ||
| JP2018527919A5 (https=) | ||
| JP2010504755A5 (https=) | ||
| JP2024541680A5 (https=) | ||
| EP3092252B1 (en) | Antibody targeting cell surface deposited complement protein c3d and use thereof | |
| JP2023540526A5 (https=) | ||
| CN114736291B (zh) | 特异性结合发热伴血小板减少综合征病毒的囊膜蛋白Gn的人源单克隆抗体及其用途 | |
| JP2020516309A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JP2023549851A5 (https=) | ||
| JP2024532489A5 (https=) | ||
| JP2023511898A5 (https=) | ||
| JP2023548529A5 (https=) | ||
| JP2022512646A5 (https=) | ||
| JP2023508674A5 (https=) |